基本情報

所属
東北大学 大学院薬学研究科 教授

J-GLOBAL ID
200901019201372845
researchmap会員ID
5000042402

Dr Kohji Fukunaga was born in 1955 in Kagoshima, Japan. He received his BSc (1978) and PhD degrees (1985) from Kumamoto University. In 1982, he first discovered calcium/calmodulin-dependent protein kinase II (CaMKII) from rat brain and extensively defined the role of CaMKII in the hippocampal synaptic plasticity and spine formation. In 2003, he also discovered critical role of fatty acid-binding protein 3 (FABP3) in the dopamine D2 receptor signaling. He has developed novel therapeutic candidates in Alzheimer’s disease (AD) for activation of CaMKII and in Lewy body dementia (LBD) for inhibition of FABP3 function. In his professional records, he joined Kumamoto University School of Medicine in 1990 as an assistant professor and was promoted to an associate professor in 1993. During 1988 to 1990 he joined as a research fellow in Howard Hughes Medical Institute (HHMI) of Vanderbilt University under Professor TR Soderling. In 2002, he was appointed professor and chairman in Department of Pharmacology, Tohoku University Graduate School of Pharmaceutical Sciences. He was Editor-in-Chief of Journal of Pharmacological Sciences (Elsevier) during 2012-2016.


論文

  423

MISC

  290

共同研究・競争的資金等の研究課題

  54